Current Drug Discovery Technologies (CDDT)

Current Drug Discovery Technologies is a peer reviewed scientific journal that focuses on innovative methods, platforms, and enabling technologies that accelerate modern drug discovery. The journal provides a dedicated forum for researchers from academia, industry, and translational science to present advances that improve the identification, design, and optimization of therapeutic agents. It covers a broad spectrum of topics including target identification and validation, medicinal chemistry strategies, structure based drug design, computational and AI driven discovery, high throughput screening, cheminformatics, systems biology, and biomarker discovery. The journal places strong emphasis on interdisciplinary approaches that bridge chemistry, biology, pharmacology, and data science. It publishes original research articles, comprehensive reviews, and short communications that highlight novel tools, workflows, and experimental or in silico techniques with clear relevance to drug discovery pipelines. Emerging areas such as biologics discovery, drug repurposing, nanotechnology based delivery concepts, and predictive toxicology are also within its scope. By showcasing both conceptual advances and practical applications, Current Drug Discovery Technologies aims to shorten development timelines and improve success rates in bringing new therapeutics to the clinic. It serves as a valuable resource for scientists, clinicians, and pharmaceutical professionals seeking up to date insights into technologies shaping the future of drug discovery.

Current Drug Discovery Technologies (CDDT) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pharmacy, Pharmacology (nursing), Pharmacology (medical), Pharmacology , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1570-1638, E-ISSN: 1875-6220, Established: 2004,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE